Alliance Medical Technologies (AMT) heart valve gets FDA panel backing:
This article was originally published in Clinica
FDA advisers recommend the agency approve Alliance Medical Technologies' Monostrut mechanical heart valve for marketing in the US. The hinge-less free-floating valve is widely used elsewhere in the world and has been implanted in 115,000 patients in 33 countries, says AMT.
You may also be interested in...
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.
Shares in Iovance Biotherapeutics have soared this week amid reports the US clinical-stage biotechnology company is in active M&A talks.